Total revenues in the third quarter were $42 billion, up 10.5% year over year.
Total net earnings in the third quarter were $713 million, up 52% since the same period last year.
The company reaffirmed its year-end adjusted EPS guidance of greater than $6.80.
The company’s medical loss ratio was 89.2% in the third quarter and 87% during the same period last year. Days claims payable were 51 in the third quarter, compared to 53 a year ago.
As of Sept. 30, Centene’s total membership stands at more than 28.6 million. Medicaid membership has fallen to 13.1 million, decreasing 14.2% year over year. There are 4.5 million exchange members, 426,000 commercial group members, 1.1 million Medicare Advantage and supplement members, and 6.8 million Medicare prescription drug plans.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.